Corneal permeation of ganciclovir: Mechanism of ganciclovir permeation enhancement by acyl ester prodrug design

Journal of Ocular Pharmacology and Therapeutics

Volumn 18, Issue 6, 2002, Pages 535-548

  Tirucherai, Giridhar S ^a   Dias, Clapton ^a   Mitra, Ashim K ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CARBON; ESTER; GANCICLOVIR; GANCICLOVIR MONOACETATE; GANCICLOVIR MONOBUTYRATE; GANCICLOVIR MONOPROPIONATE; GANCICLOVIR MONOVALERATE; PRODRUG; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA; CORNEA EPITHELIUM; DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG DIFFUSION; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG UPTAKE; HYDROLYSIS; LIPOPHILICITY; MALE; NONHUMAN; PARTITION COEFFICIENT; RABBIT;

EID: 0036907858     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/108076802321021081     Document Type: Article

References (29)

1. Sudesh, S., and Laibson, P.R. The impact of the herpetic eye disease studies on the management of herpes simplex virus ocular infections. Curr. Opin. Ophthalmol. 10:230-233, 1999.
2. Easty, D.L. Clinical Aspects of Ocular Herpes Simplex Virus Infection, Year Book Medical Publishers, Chicago, 1995.
3. Suresh, P.S., and Tullo, A.B. Herpes simplex keratitis. Indian J. Ophthalmol. 47:155-165, 1999.
4. Coster, D.J., Jones, B.R., and Falcon, M.G. Role of debridement in the treatment of herpetic keratitis. Trans. Ophthalmol. Soc. U K 97:314-317, 1977.
5. Collum, L.M., Benedict-Smith, A., and Hillary, I.B. Randomised double-blind trial of acyclovir and idoxuridine in dendritic corneal ulceration. Br. J. Ophthalmol. 64:766-769, 1980.
6. Power, W.J., Benedict-Smith, A., Hillery, M., Brady, K., and Collum, L.M. Bromovinyldeoxyuridine (BVDU) and trifluorothymidine (TFT) in dendritic corneal ulceration: A double blind controlled study. Curr. Eye Res. 10:183-187, 1991.
7. Laibson, P.R., Arentsen, J.J., Mazzanti, W.D., and Eiferman, R.A. Double controlled comparison of IDU and trifluorothymidine in thirty-three patients with superficial herpetic keratitis. Trans. Am. Ophthalmol. Soc. 75:316-324, 1977.
8. McGill, J., Tormey, P., and Walker, C.B. Comparative trial of acyclovir and adenine arabinoside in the treatment of herpes simplex corneal ulcers. Br. J. Ophthalmol. 65:610-613, 1981.
9. Collum, L.M., Logan, P., McAuliffe-Curtin, D., Hung, S.O., Patterson, A., and Rees, P.J. Randomised double-blind trial of acyclovir (Zovirax) and adenine arabinoside in herpes simplex amoeboid corneal ulceration. Br. J. Ophthalmol. 69:847-850, 1985.
10. Colin, J., Tournoux, A., Chastel, C., and Renard, G. Superficial herpes simplex keratitis. Double-blind comparative trial of acyclovir and idoxuridine (author's transl). Nouv. Presse Med. 10:2969-2970, 2975, 1981.
11. la Lau, C., Oosterhuis, J.A., Versteeg, J., van Rij, G., Renardel de Lavalette, J.G., Craandijk, A., and Lamers, W.P. Acyclovir and trifluorothymidine in herpetic keratitis: A multicentre trial. Br. J. Ophthalmol. 66:506-508, 1982.
12. Elion, G.B., Furman, P.A., Fyfe, J.A., de Miranda, P., Beauchamp, L., and Schaeffer, H.J. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc. Natl. Acad. Sci. U S A 74:5716-5720, 1977.
13. Shiota, H., Naito, T., and Mimura, Y. Anti-herpes simplex virus (HSV) effect of 9-(1, 3-dihydroxy-2-propoxymethyl)guanine (DHPG) in rabbit cornea. Curr. Eye Res. 6:241-245, 1987.
14. Naito, T., Nitta, K., Kinouchi, Y., Shiota, H., and Mimura, Y. Effects of 9-(1, 3-dihydroxy-2-propoxymethyl) guanine (DHPG) eye drops and cyclosporine eye drops in the treatment of herpetic stromal keratitis in rabbits. Curr. Eye Res. 10:201-203, 1991.
15. Hoh, H.B., Hurley, C., Claoue, C., Viswalingham, M., Easty, D.L., Goldschmidt, P., and Collum, L.M. Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: A multicentre study. Br. J. Ophthalmol. 80:140-143, 1996.
16. Hughes, P.M., Krishnamoorthy, R., and Mitra, A.K. Effect of acylation on the ocular disposition of acyclovir. I: Synthesis, physicochemical properties, and antiviral activity of 2′-esters. J. Ocul. Pharmacol. 9:287-297, 1993.
17. Krishnamoorthy, R. Ocular Pigmentation Effects on the Intravitreal Disposition of Novel Acyclo Guanosine Analogs, Ph.D. Thesis. Purdue University, 1995.
18. Castela, N., Vermerie, N., Chast, F., Sauvageon-Martre, H., Denis, J., Godard, V., Goldschmidt, P., and Pouliquen, Y. Ganciclovir ophthalmic gel in herpes simplex virus rabbit keratitis: Intraocular penetration and efficacy. J. Ocul. Pharmacol. 10:439-451, 1994.
19. Fresta, M., Fontana, G., Bucolo, C., Cavallaro, G., Giammona, G., and Puglisi, G. Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir. J. Pharm. Sci. 90:288-297, 2001.
20. Chang, S.C., Bundgaard, H., Buur, A., and Lee, V.H. Improved corneal penetration of timolol by prodrugs as a means to reduce systemic drug load. Invest. Ophthalmol. Vis. Sci. 28:487-491, 1987.
21. Narurkar, M.M., and Mitra, A.K. Prodrugs of 5-iodo-2′-deoxyuridine for enhanced ocular transport. Pharm. Res. 6:887-891, 1989.
22. Bundgaard, H., Falch, E., Larsen, C., Mosher, G.L., and Mikkelson, T.J. Pilocarpine prodrugs. II. Synthesis, stability, bioconversion, and physicochemical properties of sequentially labile pilocarpine acid diesters. J. Pharm. Sci. 75:775-783, 1986.
23. Yuan, S.S., and Bador, N. Synthesis and activity of (R)-(-)-m-trimethylacetoxy-alpha-[(methylamino)methyl]benzyl alcohol hydrochloride: A prodrug form of (R)-(-)-phenylephrine. J. Pharm. Sci. 65:929-931, 1976.
24. Hughes, P.M., and Mitra, A.K. Effect of acylation on the ocular disposition of acyclovir. II: Corneal permeability and anti-HSV 1 activity of 2′-esters in rabbit epithelial keratitis. J. Ocul. Pharmacol. 9:299-309, 1993.
25. Gao, H., and Mitra, A.K. Regioselective synthesis of various prodrugs of ganciclovir. Tetrahedron Letters 41:1131-1136, 2000.
26. Dias, C.S., Anand, B., and Mitra, A.K. Effect of mono and di acylation on the ocular disposition of ganciclovir: Physicochemical properties, ocular bioreversion and anti viral activity of short chain ester prodrugs. J. Pharm. Sci. 91:660-668, 2002.
27. Tak, R.V., Pal, D., Gao, H., Dey, S., and Mitra, A.K. Transport of acyclovir ester prodrugs through rabbit cornea and SIRC rabbit corneal epithelial cell line. J. Pharm. Sci. 90:1505-1515, 2001
28. Grass, G.M., and Robinson, J.R. Mechanisms of corneal drug penetration. I: In vivo and in vitro kinetics. J. Pharm. Sci. 77:3-14, 1988.
29. Lee, V.H., Chang, S.C., Oshiro, C.M., and Smith, R.E. Ocular esterase composition in albino and pigmented rabbits: Possible implications in ocular prodrug design and evaluation. Curr. Eye Res. 4:1117-1125, 1985.